美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

減肥藥

1,143.99

+9.310.82%

漲家數：5

跌家數：2

平家數：- -

市盈率：- -

高：1,154.62

開：1,132.71

低：1,132.71

收：1,134.68

成交量：1.34億

成交額：85.90億

市值：1.22萬億

流通市值：1.15萬億

資料載入中...

World Liberty Financial代幣WLFI在ALT5交易中估值0.2美元

輝瑞的聯合療法提高了膀胱癌試驗的生存率

一支疫苗都沒做出來，GSK“躺賺”3億美元

三生製藥老牌藥企煥新機，攜輝瑞塑百億重磅

輝瑞8月11日成交額為9.40億美元

Novo Nordisk A/S8月11日成交額為5388.12萬美元

安進8月11日成交額為5.31億美元

Altimmune, Inc.8月11日成交額為948.90萬美元

輝瑞：腫瘤架構大調整

生物药大时代

碩迪生物盤中異動臨近收盤快速拉昇5.00%報17.13美元

禮來盤中異動股價大漲3.00%

半年狂攬166億美元登頂司美格魯肽重新詮釋“全球藥王”內涵

專利糾紛和解！GSK分羹3.7億美元，輝瑞/BioNTech認栽買單？

医药经济报

諾和諾德歐股延續漲勢上漲逾2%

諾和諾德歐股上漲逾2%延續上週漲勢。

全球醫藥史上最貴的教訓

“減肥神藥”司美格魯肽遇冷，母公司市值單日蒸發930億美元

Ofweek维科网

130億美元彈藥就緒！輝瑞2025H1業績暗藏“鈔能力”

醫藥生物行業週報：關注減肥藥潛在BD機會

替爾泊肽賣爆了！銷量暴增46%，禮來第二季度盈利超預期

GLP1减重宝典

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4599/news?page=6"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"減肥藥","latestPrice":1143.9899,"timestamp":1755633599999,"preClose":1134.6772,"halted":0,"volume":133627986,"delay":0,"changeRate":0.008207,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":9.312622,"latestTime":"08-19 16:00:00 EDT","open":1132.7133,"high":1154.6233,"low":1132.71,"amount":8590118716.469341,"amplitude":0.019312,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1755676800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":8.282627,"peRate":24.521837,"turnoverRate":0.012624,"increases":5,"decrements":2,"flats":0,"marketCap":1215941649984,"floatMarketCap":1145475764960},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1154.6233,"amplitude":0.019312,"preClose":1134.6772,"low":1132.71,"pbRate":"8.282627","latestPrice":1143.9899,"volume":133627986,"delay":0,"open":1132.7133,"prevYearClose":1305.0607,"prevWeekClose":1132.9453,"prevMonthClose":1136.9344,"prevQuarterClose":1245.5326,"fiveDayClose":1057.4221,"twentyDayClose":1253.981,"sixtyDayClose":1173.4421,"secType":"PLATE","market":"US","turnoverRate":0.012624,"peRate":24.521837,"marketCap":1215941649984,"floatMarketCap":1145475764960,"timestamp":1755633599999,"nameCN":"減肥藥"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":5,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2558463116","title":"World Liberty Financial代幣WLFI在ALT5交易中估值0.2美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558463116","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558463116?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 18:24","pubTimestamp":1754994258,"startTime":"0","endTime":"0","summary":"<div class=\"line-clamp-4 text-custom-000000/70 dark:text-custom-FFFFFF/60 text-18 font-400 tracking-1 leading-40 whitespace-pre-line\"><p>Odaily星球日报讯 World Liberty Financial 与 ALT 5 Sigma Corporation 达成协议，在此次交易中首次为 WLFI 代币定价，每枚 0.2 美元。ALT 5 计划转型为加密财库公司，发行 20 万股新股并将所得用于收购价值 15 亿美元的 WLFI，其中一半新股将直接与 World Liberty Financial 所持 WLFI 交换。该项目曾于去年 10 月至今年 3 月出售价值 5.5 亿美元的 WLFI 代币，大持仓者包括波场创始人孙宇晨。ALT 5 还将 World Liberty Financial CEO Zach Witkoff、COO Zak Folkman 及美国现任总统特朗普之子 Eric Trump 等增补为董事会成员，三人均持有 WLFI。（DLNews）</p></div>","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/zh-CN/newsflash/443007","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["BK4585","COO","ALT","BK4139","LU2211815571.USD","BK4198","LU2272731600.USD","GB00BDT5M118.USD","LU1878469433.USD","LU1992135399.USD","BK4599","LU1992135472.HKD","LU2272731782.SGD","BK4588"],"gpt_icon":0},{"id":"2558643356","title":"輝瑞的聯合療法提高了膀胱癌試驗的生存率","url":"https://stock-news.laohu8.com/highlight/detail?id=2558643356","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558643356?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 17:30","pubTimestamp":1754991016,"startTime":"0","endTime":"0","summary":"辉瑞的联合疗法提高了膀胱癌试验的生存率路透8月12日 - 辉瑞公司PFE.N周二称，其抗癌药物Padcev与默克公司MRK.N的Keytruda联用，在手术前后给药可显著提高肌肉浸润性膀胱癌患者的生存率。在肌肉浸润性膀胱癌中，肿瘤超出了内膜，穿透了器官的肌肉壁。辉瑞公司表示，它计划与全球卫生机构讨论试验结果，以便进行潜在的监管申报。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ccbdaac7529898eaa28924cf0b474c7c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nL4T3U40OP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948541.HKD","LU1066051225.USD","LU1571399168.USD","LU1934455863.HKD","LU0106261372.USD","IE00BLSP4239.USD","LU0321505439.SGD","IE00BBT3K403.USD","LU1291159041.SGD","LU2023250843.SGD","BK4585","BK4599","LU1023059063.AUD","SG9999001176.USD","LU1989772840.SGD","IE00BN8TJ469.HKD","LU1941712348.USD","LU0965509010.AUD","LU1093756325.SGD","LU1037948897.HKD","LU1989771016.USD","LU1883839398.USD","LU1066053197.SGD","LU1116320901.HKD","LU1983299246.USD","LU0861579265.USD","LU0211331839.USD","LU2106854487.HKD","LU1894683348.USD","LU1929549753.HKD","PFE","SG9999002232.USD","BK4592","LU1093756168.USD","IE00BJJMRZ35.SGD","SG9999013999.USD","LU0965508806.USD","MRK","SG9999014575.USD","LU1934455277.USD","SG9999001440.SGD","LU0306806265.USD","LU0058720904.USD","BK4559","LU0985481810.HKD","SG9999015358.SGD","LU1974910355.USD","LU0122379950.USD","LU1934455194.USD","IE000M9KFDE8.USD"],"gpt_icon":1},{"id":"2558648992","title":"一支疫苗都沒做出來，GSK“躺賺”3億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558648992","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558648992?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 16:29","pubTimestamp":1754987396,"startTime":"0","endTime":"0","summary":"最终，CureVac将收到来自BioNTech的3.7亿美金和解款项，CureVac的合作伙伴GSK作为相关方能直接获得3.2亿美元。去年4月，GSK加入了对辉瑞新冠疫苗的专利围猎，指控其侵犯了自身mRNA的技术专利。在诉讼中，GSK声称辉瑞和BioNTech的新冠疫苗侵犯了其拥有的五项在美专利，这两家公司在没有获得许可的情况下获得了数十亿美元的收益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081216362197429d1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081216362197429d1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","SG9999003800.SGD","BK4534","BK4599","IE00BLSP4452.SGD","LU0456855351.SGD","LU1057294990.SGD","LU1829250122.USD","BK4581","LU0170899867.USD","SG9999013999.USD","GSK.UK","LU0868494617.USD","LU0225284248.USD","LU1023059063.AUD","LU0306807586.USD","SG9999002232.USD","IE00B19Z3B42.SGD","IE0002270589.USD","LU0234572021.USD","LU1894683348.USD","IE00BBT3K403.USD","SGXZ57979304.SGD","LU0321505868.SGD","SG9999001176.USD","BK4550","LU0306806265.USD","BK4533","IE000M9KFDE8.USD","GSK","LU0985481810.HKD","SG9999001176.SGD","SG9999002224.SGD","SG9999011175.SGD","LU0122379950.USD","LU0225771236.USD","LU0321505439.SGD","PFE","BK4007","BK4585","IE00BLSP4239.USD","IE00B19Z3581.USD","LU0058720904.USD","LU0289739699.SGD","LU1894683264.USD","BK4592","LU1883839398.USD","BK4532","LU1066053197.SGD","BK4588"],"gpt_icon":1},{"id":"2558105206","title":"三生製藥老牌藥企煥新機，攜輝瑞塑百億重磅","url":"https://stock-news.laohu8.com/highlight/detail?id=2558105206","media":"华泰证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558105206?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 16:16","pubTimestamp":1754986564,"startTime":"0","endTime":"0","summary":"首次覆盖三生制药给予“买入”评级，目标价46.32港元。三生制药是中国生物制药领军企业，拥有市占率领先的已上市药品、丰富且重磅的在研管线、高水平的生产制造及营销能力。我们认为公司正在迈入发展新阶段，并看好其创新药突围与全球化进程。强大的商业化能力三生制药是中国商业化能力最强的制药企业之一，拥有近3000人的销售团队，覆盖内地超过11000家医院，销售人均创收超300万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812163613a6e144c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812163613a6e144c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BLSP4452.SGD","LU1023059063.AUD","SGXZ57979304.SGD","IE00B19Z3581.USD","IE00BLSP4239.USD","LU0456855351.SGD","BK4581","LU0306807586.USD","BK4533","LU1066053197.SGD","IE00B19Z3B42.SGD","LU1057294990.SGD","LU0321505439.SGD","LU1894683348.USD","LU1066051498.USD","LU0170899867.USD","BK4585","IE0002270589.USD","BK4599","LU0225284248.USD","LU0234572021.USD","PFE","SG9999011175.SGD","LU0122379950.USD","LU0225771236.USD","BK4007","LU0306806265.USD","LU1894683264.USD","LU0985481810.HKD","SG9999001176.USD","LU0868494617.USD","IE00BBT3K403.USD","BK4568","LU0289739699.SGD","BK4592","LU0058720904.USD","BK4534","SG9999013999.USD","LU0321505868.SGD","SG9999002232.USD","LU1883839398.USD","IE000M9KFDE8.USD","SG9999003800.SGD","SG9999001176.SGD","SG9999002224.SGD","BK4588","BK4550"],"gpt_icon":1},{"id":"2558615466","title":"輝瑞8月11日成交額為9.40億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558615466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558615466?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 13:13","pubTimestamp":1754975587,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，辉瑞成交额为9.40亿美元，成交额较昨日增加5.64%，当日成交量为3811.57万股。辉瑞于2025年8月11日涨0.0%，报24.58美元，该股过去5个交易日涨4.46%，年初至今跌2.36%，过去60日涨13.56%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-11|9.40亿|5.64%|3811.57万|#|2025-08-08|8.90亿|-19.23%|3637.70万|#|2025-08-07|11.02亿|-30.32%|4549.44万|#|2025-08-06|15.82亿|-43.53%|6568.92万|#|2025-08-05|28.01亿|108.47%|1.14亿|辉瑞是世界上最大的制药公司之一，年销售额约为600亿美元。辉瑞在全球销售这些产品，国际销售额占总销售额的40%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812131314a48350b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812131314a48350b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PFE","LU0289739699.SGD","SG9999011175.SGD","LU1883839398.USD","LU0170899867.USD","LU0225771236.USD","LU0321505439.SGD","BK4007","BK4568","LU0456855351.SGD","LU1894683264.USD","BK4592","BK4585","BK4550","IE00BBT3K403.USD","BK4599","LU0058720904.USD","LU1894683348.USD","SG9999013999.USD","IE0002270589.USD","LU0225284248.USD","SG9999002232.USD","IE00B19Z3581.USD","LU0321505868.SGD","LU1066051498.USD","LU0985481810.HKD","LU1023059063.AUD","SGXZ57979304.SGD","IE000M9KFDE8.USD","LU1057294990.SGD","SG9999003800.SGD","BK4581","LU1066053197.SGD","IE00BLSP4452.SGD","BK4533","IE00BLSP4239.USD","LU0868494617.USD","SG9999001176.SGD","IE00B19Z3B42.SGD","BK4534","LU0234572021.USD","LU0306806265.USD","LU0122379950.USD","SG9999001176.USD","BK4588","LU0306807586.USD","SG9999002224.SGD"],"gpt_icon":1},{"id":"2558613145","title":"Novo Nordisk A/S8月11日成交額為5388.12萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558613145","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558613145?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 12:43","pubTimestamp":1754973794,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Novo Nordisk A/S成交额为5388.12万美元，成交额较昨日增加3475.28%，当日成交量为107.62万股。Novo Nordisk A/S于2025年8月11日跌1.71%，报49.58美元，该股过去5个交易日涨0.53%，年初至今跌41.32%，过去60日跌22.54%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-11|5388.12万|3475.28%|107.62万|#|2025-08-08|150.70万|-95.52%|2.99万|#|2025-08-07|3363.61万|-61.25%|69.91万|#|2025-08-06|8680.51万|100.92%|191.04万|#|2025-08-05|4320.29万|5661.82%|90.93万|诺和诺德拥有全球约三分之一的品牌糖尿病治疗市场，是全球领先的糖尿病护理产品供应商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812124322a4834419&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812124322a4834419&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","IE00BZ1G4Q59.USD","LU1093756168.USD","NVO","LU0154236417.USD","IE00BKVL7J92.USD","BK4585","BK4532","LU1093756325.SGD","BK4588","NONOF","BK4599"],"gpt_icon":1},{"id":"2558694521","title":"安進8月11日成交額為5.31億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558694521","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558694521?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 09:16","pubTimestamp":1754961405,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，安进成交额为5.31亿美元，成交额较昨日增加2.42%，当日成交量为185.68万股。安进于2025年8月11日跌1.09%，报285.09美元，该股过去5个交易日跌5.58%，年初至今涨11.24%，过去60日涨9.66%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812091655a6e08105&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812091655a6e08105&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B4R5TH58.HKD","LU2242646821.SGD","LU0868494617.USD","LU2468319806.SGD","LU0889565916.HKD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU2089984988.USD","AMGN","LU1023059063.AUD","LU1983299246.USD","BK4588","BK4139","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4599","BK4581","LU1061106388.HKD","IE00BFTCPJ56.SGD","LU2242652126.USD","IE0009355771.USD","LU0320765992.SGD","IE0002141913.USD","BK4585","LU0058720904.USD","LU0109394709.USD","BK4566","LU1057294990.SGD","SG9999001440.SGD","LU0122379950.USD","LU1571399168.USD","LU2112291526.USD","BK4534","BK4533"],"gpt_icon":0},{"id":"2558691222","title":"Altimmune, Inc.8月11日成交額為948.90萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558691222","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558691222?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 09:16","pubTimestamp":1754961394,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Altimmune, Inc.成交额为948.90万美元，成交额较昨日增加18.24%，当日成交量为278.66万股。Altimmune, Inc.于2025年8月11日跌2.03%，报3.38美元，该股过去5个交易日跌5.59%，年初至今跌53.12%，过去60日跌40.7%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-11|948.90万|18.24%|278.66万|#|2025-08-08|802.54万|-6.68%|230.81万|#|2025-08-07|860.04万|34.15%|243.00万|#|2025-08-06|641.12万|-31.15%|178.62万|#|2025-08-05|931.14万|36.62%|253.61万|Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812091640a6e080e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812091640a6e080e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1878469433.USD","BK4599","ALT"],"gpt_icon":0},{"id":"2558699803","title":"輝瑞：腫瘤架構大調整","url":"https://stock-news.laohu8.com/highlight/detail?id=2558699803","media":"生物药大时代","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558699803?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 08:08","pubTimestamp":1754957329,"startTime":"0","endTime":"0","summary":"近日，辉瑞中国正式宣布，对肿瘤及罕见病事业部进行组织架构优化。此次调整后的新架构将于2025年8月11日起正式生效，其中肺癌治疗领域的架构将于2025年9月1日启动实施。近年来，辉瑞中国在肿瘤及罕见病领域持续取得突破性进展，包括推动多款重磅创新药物在中国成功上市，并在临床应用和市场拓展方面取得优异表现。在携带ESR1突变的所有患者亚群当中，vepdegestrant的获益情形一致。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812081936a482c83b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812081936a482c83b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0225284248.USD","LU1883839398.USD","BK4007","IE00B19Z3B42.SGD","LU1894683348.USD","LU0306807586.USD","BK4585","SG9999002224.SGD","SG9999003800.SGD","SG9999013999.USD","BK4568","IE000M9KFDE8.USD","BK4592","LU0985481810.HKD","LU1066051498.USD","IE0002270589.USD","LU0234572021.USD","SG9999001176.USD","SG9999011175.SGD","BK4534","PFE","LU0225771236.USD","LU0321505439.SGD","SGXZ57979304.SGD","LU0122379950.USD","LU1066053197.SGD","LU0306806265.USD","LU0868494617.USD","LU1894683264.USD","IE00BBT3K403.USD","IE00BLSP4239.USD","BK4550","LU0456855351.SGD","SG9999002232.USD","LU0058720904.USD","IE00BLSP4452.SGD","LU1023059063.AUD","BK4588","BK4581","SG9999001176.SGD","LU0289739699.SGD","LU0321505868.SGD","LU1057294990.SGD","LU0170899867.USD","BK4599","BK4533","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2558603436","title":"碩迪生物盤中異動 臨近收盤快速拉昇5.00%報17.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558603436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558603436?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 03:42","pubTimestamp":1754941377,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日03时42分，硕迪生物股票出现波动，股价快速拉升5.00%。截至发稿，该股报17.13美元/股，成交量71.375万股，换手率1.24%，振幅6.68%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-61.88百万美元，每股收益-1.08美元，毛利-853991.71美元，市盈率-5.43倍。机构评级方面，在所有12家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体跌幅为0.48%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812034258a6e0195c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812034258a6e0195c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4599","GPCR"],"gpt_icon":0},{"id":"2558666904","title":"禮來盤中異動 股價大漲3.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558666904","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558666904?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 22:06","pubTimestamp":1754921186,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日22时06分，礼来股票出现异动，股价急速上涨3.00%。礼来股票所在的制药行业中，整体涨幅为1.23%。该信息摘要如下：截至8月8日早间美股收盘，礼来股价下跌14.14%，创2000年8月以来最大单日跌幅，诺和诺德股价上涨7.45%。财报显示，礼来二季度营收155.58亿美元，同比增长37.64%；净利润56.61亿美元，同比增长90.78%。礼来解释称符合口服单激动剂预期特征，患者退出可能有多种原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811220627a48224f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811220627a48224f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015978.USD","LU0289739699.SGD","LU1804176565.USD","LU0079474960.USD","SGXZ51526630.SGD","LU2237443895.HKD","LU0466842654.USD","BK4516","LU1712237335.SGD","BK4007","LU2063271972.USD","LLY","LU1280957306.USD","LU0882574055.USD","LU1814569148.SGD","LU2552382215.SGD","LU0354030511.USD","LU1868837136.USD","LU0238689110.USD","BK4599","LU2357305700.SGD","LU2089984988.USD","LU1291159041.SGD","SG9999013999.USD","IE0009355771.USD","LU0097036916.USD","LU1023059063.AUD","LU1061106388.HKD","LU1868836757.USD","LU1988902786.USD","LU2265009873.SGD","LU0106261372.USD","LU2471134523.USD","BK4581","LU1035775433.USD","LU2491049909.HKD","LU0708995401.HKD","LU0943347566.SGD","SG9999001176.SGD","LU2237443465.HKD","LU2468319806.SGD","LU0096364046.USD","BK4534","LU0234572021.USD","LU0689472784.USD","LU2264538146.SGD","LU0889565916.HKD","LU0198837287.USD","LU1366192091.USD","LU2750360997.AUD"],"gpt_icon":1},{"id":"2558413657","title":"半年狂攬166億美元登頂 司美格魯肽重新詮釋“全球藥王”內涵","url":"https://stock-news.laohu8.com/highlight/detail?id=2558413657","media":"每经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558413657?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 19:37","pubTimestamp":1754912259,"startTime":"0","endTime":"0","summary":"从首次获批到以166亿美元的半年销售额登顶“全球药王”，司美格鲁肽用8年时间便改写了全球医药市场的格局。半年狂揽166亿美元，登顶“全球药王”诺和诺德发布的2025年上半年财报显示，今年上半年，公司实现营收1549.44亿丹麦克朗，同比增长18%；中国区收入99.10亿丹麦克朗。2021年6月，美国FDA批准司美格鲁肽以商品名Wegovy用于减重适应证。仅仅半年后，三款产品半年合计收入1127.56亿丹麦克朗，登顶“全球药王”宝座。肥胖已经成为全球的公共健康问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508111945449740bc0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508111945449740bc0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVO","IE00BKVL7J92.USD","BK4007","LU1093756325.SGD","IE00BZ1G4Q59.USD","BK4599","BK4532","BK4588","LU1093756168.USD","LU0154236417.USD","BK4585","CEO"],"gpt_icon":1},{"id":"2558540406","title":"專利糾紛和解！GSK分羹3.7億美元，輝瑞/BioNTech認栽買單？","url":"https://stock-news.laohu8.com/highlight/detail?id=2558540406","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558540406?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 18:22","pubTimestamp":1754907732,"startTime":"0","endTime":"0","summary":"日前，德国生物科技公司CureVac宣布与辉瑞和BioNTech达成协议，解决并终止关于mRNA相关疫苗的所有未决专利纠纷。CureVac彼时的股价还因此飙升11%，而BioNTech则面临专利侵权风险。GSK表示，该和解协议不会影响其在美国和欧洲对辉瑞和BioNTech的专利执行，针对二者侵犯相关专利的诉讼仍将继续。据报道，GSK于2024年4月对辉瑞与BioNTech提起的另一起诉讼仍在进行中。GSK称辉瑞与BioNTech从这些侵权中获得了数十亿美元的收入并继续收益，而从未获得许可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811183801a481d196&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811183801a481d196&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BLSP4452.SGD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0234572021.USD","LU0225771236.USD","BK4581","SG9999002232.USD","BK4599","LU1057294990.SGD","BK4592","LU0122379950.USD","BK4534","SGXZ57979304.SGD","SG9999013999.USD","BK4585","LU1894683264.USD","SG9999011175.SGD","LU0321505439.SGD","LU0289739699.SGD","LU0170899867.USD","IE00B19Z3581.USD","LU0306807586.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU0321505868.SGD","SG9999001176.USD","SG9999003800.SGD","LU0058720904.USD","LU1883839398.USD","SG9999002224.SGD","LU1066053197.SGD","BK4550","BK4568","IE00BBT3K403.USD","GSK.UK","LU0225284248.USD","PFE","BK4007","LU1894683348.USD","LU1829250122.USD","IE0002270589.USD","LU1066051498.USD","GSK","LU0456855351.SGD","LU0985481810.HKD","BK4533","BK4588","IE00BLSP4239.USD","LU0868494617.USD","BK4532"],"gpt_icon":1},{"id":"2558637551","title":"諾和諾德歐股延續漲勢 上漲逾2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558637551","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558637551?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 15:46","pubTimestamp":1754898362,"startTime":"0","endTime":"0","summary":"2025年8月11日，诺和诺德欧股延续上周涨势，当日上涨逾2%。此次上涨主要受市场对其最新财报预期的积极反应影响，投资者信心持续增强。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081115524697406cb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081115524697406cb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ1G4Q59.USD","LU1093756325.SGD","LU1093756168.USD","NVO","BK4007","IE00BKVL7J92.USD","BK4532","BK4585","BK4599","LU0154236417.USD","BK4588"],"gpt_icon":0},{"id":"2558634445","title":"諾和諾德歐股上漲逾2%延續上週漲勢。","url":"https://stock-news.laohu8.com/highlight/detail?id=2558634445","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558634445?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 15:08","pubTimestamp":1754896081,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1093756168.USD","BK4599","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4585","BK4532","BK4007","NVO","BK4588","IE00BKVL7J92.USD","LU0154236417.USD"],"gpt_icon":0},{"id":"2558633284","title":"全球醫藥史上最貴的教訓","url":"https://stock-news.laohu8.com/highlight/detail?id=2558633284","media":"氨基观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558633284?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 11:01","pubTimestamp":1754881288,"startTime":"0","endTime":"0","summary":"截至目前，礼来最新市值为6065亿美元。曾不断刷新全球药企市值纪录的礼来，不经意间，又在医药史上留下了最昂贵的教训。诺和诺德的司美格鲁肽正式获FDA批准用于减重。今年5月份礼来公布的一项头对头研究，证明了这一点。然而，礼来计划赶不上变化，减肥药领域的变数接连而至。就在公布Orforglipron最新结果的同一天，礼来将全财年营收预期上调至600亿美元至620亿美元，高于此前预计的580亿美元至610亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811111611a6debf91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811111611a6debf91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","LLY","IE00BZ1G4Q59.USD","BK4599","BK4585","BK4588","BK4007","L","LU0210528500.USD","LU2487616109.SGD","IE00BKVL7J92.USD","NVO","LU1093756325.SGD","LU1093756168.USD","LU0053666078.USD","BK4107","LU0154236417.USD"],"gpt_icon":1},{"id":"2558335036","title":"“減肥神藥”司美格魯肽遇冷，母公司市值單日蒸發930億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558335036","media":"Ofweek维科网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558335036?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 10:59","pubTimestamp":1754881196,"startTime":"0","endTime":"0","summary":"然而市场对此反应极为冷淡，截至8月8日，公司股价单日暴跌21.8%，市值2267亿美元，市值单日蒸发930亿美元，创下公司百年历史上最大单日跌幅。此后几个交易日，诺和诺德股价继续延续下跌趋势，四个交易日股价跌幅超过了30%，市值蒸发超过了920亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811110050973ffef7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811110050973ffef7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4007","LU1093756325.SGD","NVO","BK4599","LU0154236417.USD","BK4532","BK4585","BK4588"],"gpt_icon":1},{"id":"2558684707","title":"130億美元彈藥就緒！輝瑞2025H1業績暗藏“鈔能力”","url":"https://stock-news.laohu8.com/highlight/detail?id=2558684707","media":"药事纵横","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558684707?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 06:04","pubTimestamp":1754863442,"startTime":"0","endTime":"0","summary":"Nurtec ODT/Vydura作为辉瑞斥资116亿美元收购Biohaven公司获得的产品，在2025H1贡献了6.07亿美元收入，同比增长14%。RSV疫苗Abrysvo在2023年上市后，迅速获得市场认可，2025H1创收2.74亿美元，同比增长36%。并购成效：Seagen资产释放红利2023年底，辉瑞以430亿美元收购Seagen，这一重磅交易在2025H1展现出显著的协同效应，收购资产合计创收17.52亿美元 ，成为辉瑞业绩增长的重要支撑。BD战略：130亿弹药的未来投向在业务拓展与创新布局的战略规划下，辉瑞展现出积极进取的态势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811060755a48099da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811060755a48099da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","SG9999003800.SGD","BK4534","BK4599","IE00BLSP4452.SGD","LU0456855351.SGD","LU1057294990.SGD","SG9999013999.USD","BK4581","LU0170899867.USD","LU1066051498.USD","LU0868494617.USD","LU0225284248.USD","LU1023059063.AUD","LU0306807586.USD","SG9999002232.USD","IE00B19Z3B42.SGD","IE0002270589.USD","LU0234572021.USD","LU1894683348.USD","IE00BBT3K403.USD","SGXZ57979304.SGD","LU0321505868.SGD","SG9999001176.USD","BK4550","LU0306806265.USD","BK4533","IE000M9KFDE8.USD","LU0985481810.HKD","SG9999001176.SGD","SG9999002224.SGD","SG9999011175.SGD","LU0122379950.USD","LU0225771236.USD","LU0321505439.SGD","PFE","BK4007","BK4585","IE00BLSP4239.USD","IE00B19Z3581.USD","LU0058720904.USD","LU0289739699.SGD","LU1894683264.USD","BK4592","LU1883839398.USD","LU1066053197.SGD","BK4588"],"gpt_icon":1},{"id":"2558638228","title":"醫藥生物行業週報：關注減肥藥潛在BD機會","url":"https://stock-news.laohu8.com/highlight/detail?id=2558638228","media":"世纪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558638228?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 00:00","pubTimestamp":1754841600,"startTime":"0","endTime":"0","summary":"2) 关注减肥药潜在BD 机会。我们认为在减肥药管线军备竞赛中，先行者礼来再次验证了GLP-1 口服药的可行性，代谢领域管线处于劣势的MNC 会考虑引入外部产品来提升竞争力，减肥药领域BD 确定性再次增强，国内biotech在减肥药领域布局广泛，管线具备全球竞争力，关注国内布局减肥药口服药的创新药企业，长线持续看好创新药方向。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811103619a48102a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811103619a48102a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","IE000M9KFDE8.USD","LU0868494617.USD","SG9999001176.USD","LU0289739699.SGD","LU1894683264.USD","BK4534","BK4550","IE0002270589.USD","SG9999002224.SGD","SG9999002232.USD","LU0456855351.SGD","BK4585","BK4599","PFE","BK4592","688265","LU0122379950.USD","LU0985481810.HKD","688108","NVO","BK4533","LU1066051498.USD","LU0234572021.USD","LU0306806265.USD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","SG9999013999.USD","SG9999003800.SGD","SGXZ57979304.SGD","LU0058720904.USD","LU0170899867.USD","LU0225284248.USD","LU1883839398.USD","IE00BLSP4452.SGD","LU0306807586.USD","688189","LU1023059063.AUD","688136","LU0225771236.USD","IE00BLSP4239.USD","LU0321505868.SGD","IE00BBT3K403.USD","BK4588","LU1066053197.SGD","BK4568","LU0321505439.SGD","LU1894683348.USD","SG9999011175.SGD","BK4581","LU1057294990.SGD","LLY","SG9999001176.SGD"],"gpt_icon":1},{"id":"2558686619","title":"替爾泊肽賣爆了！銷量暴增46%，禮來第二季度盈利超預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2558686619","media":"GLP1减重宝典","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558686619?lang=zh_tw&edition=fundamental","pubTime":"2025-08-10 17:27","pubTimestamp":1754818050,"startTime":"0","endTime":"0","summary":"整理 | GLP1减重宝典内容团队礼来公司周四公布二季度业绩优于市场预期，但备受关注的口服 GLP-1 药物试验结果令人失望，导致股价在周四早盘下跌 13%。美国市场营收 108.1 亿美元，其中 GLP-1 药物 Mounjaro与 Zepbound 的销量同比增长 46%，成为主要驱动力。但公司指出，价格下调 8% 限制了收入增幅。礼来预计将在今年向 FDA 递交该口服药的数据，若顺利获批，有望于明年上市。罕见地，诺和诺德在竞争对手承压之际主动发声。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810173623a47fec21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810173623a47fec21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LLY","LU1917777945.USD","NVO","LU1983299246.USD","LU0820561818.USD","LU1868837300.USD","LU1035775433.USD","SG9999015945.SGD","LU2089984988.USD","LU2471134952.CNY","LU2361044949.HKD","LU2361044865.SGD","LU2471134796.USD","LU2750360641.GBP","LU0320765992.SGD","LU2237443465.HKD","LU0323591593.USD","LU1127390331.HKD","LU0889565916.HKD","IE00BK4W5M84.HKD","LU1623119135.USD","SG9999018865.SGD","BK4534","LU0820561909.HKD","LU0079474960.USD","LU0471298777.SGD","LU0203202063.USD","LU0786609619.USD","LU1868836591.USD","LU0943347566.SGD","GB00BDT5M118.USD","SGXZ31699556.SGD","LU2750360997.AUD","LU2237443382.USD","LU1551013342.USD","LU0882574055.USD","LU1988902786.USD","LU2112291526.USD","SGXZ51526630.SGD","LU0417517546.SGD","BK4588","LU0109391861.USD","LU2236285917.USD","IE0009355771.USD","LU2746668974.SGD","LU1057294990.SGD","LU0882574139.USD","BK4599","BK4533","LU2106854487.HKD"],"gpt_icon":1}],"pageSize":20,"totalPage":12,"pageCount":6,"totalSize":227,"code":"91000000","status":"200"}]}}